{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:27:46Z","timestamp":1793867266565,"version":"4.6.1"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00066-026-02561-w","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:57:35Z","timestamp":1782305855000},"page":"1107-1119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac substructure dosimetry in thoracic radiotherapy: moving beyond mean heart dose and toward precision cardiac risk mitigation"],"prefix":"10.1007","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6375-7831","authenticated-orcid":false,"given":"Ahmed","family":"Sohaib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed T.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Alhefny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"6","key":"2561_CR1","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/cncr.21324","volume":"104","author":"G Delaney","year":"2005","unstructured":"Delaney\u00a0G, Jacob\u00a0S, Featherstone\u00a0C, Barton\u00a0M (2005) The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104(6):1129\u20131137","journal-title":"Cancer"},{"issue":"5","key":"2561_CR2","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","volume":"109","author":"BM Aleman","year":"2007","unstructured":"Aleman\u00a0BM, van den Belt-Dusebout\u00a0AW, De Bruin\u00a0ML et\u00a0al (2007) Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109(5):1878\u20131886","journal-title":"Blood"},{"issue":"11","key":"2561_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby\u00a0SC, Ewertz\u00a0M, McGale\u00a0P et\u00a0al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368(11):987\u2013998","journal-title":"N Engl J Med"},{"key":"2561_CR4","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/1754-9485.13737","volume":"68","author":"S Bowen Jones","year":"2024","unstructured":"Bowen Jones\u00a0S, Marchant\u00a0T, Saunderson\u00a0C, McWilliam\u00a0A, Banfill\u00a0K (2024) Moving beyond mean heart dose: the importance of cardiac substructures in radiation therapy toxicity. J\u00a0Med Imaging Radiat Oncol 68:974\u2013986","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"4","key":"2561_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41416-024-02888-0","volume":"132","author":"GM Walls","year":"2025","unstructured":"Walls\u00a0GM, Bergom\u00a0C, Mitchell\u00a0JD et\u00a0al (2025) Cardiotoxicity following thoracic radiotherapy for lung cancer. Br J Cancer 132(4):311\u2013325","journal-title":"Br J Cancer"},{"issue":"4","key":"2561_CR6","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jaccao.2024.07.005","volume":"6","author":"KM Atkins","year":"2024","unstructured":"Atkins\u00a0KM, Zhang\u00a0SC, Kehayias\u00a0C et\u00a0al (2024) Cardiac substructure radiation dose and associations with tachyarrhythmia and bradyarrhythmia after lung cancer radiotherapy. JACC CardioOncol 6(4):544\u2013556","journal-title":"JACC CardioOncol"},{"issue":"5","key":"2561_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jtho.2023.01.085","volume":"18","author":"A McWilliam","year":"2023","unstructured":"McWilliam\u00a0A, Abravan\u00a0A, Banfill\u00a0K, Faivre-Finn\u00a0C, van Herk\u00a0M (2023) Demystifying the results of RTOG 0617: identification of dose sensitive cardiac subregions associated with overall survival. J\u00a0Thorac Oncol 18(5):599\u2013607","journal-title":"J Thorac Oncol"},{"issue":"5","key":"2561_CR8","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.ijrobp.2022.11.033","volume":"115","author":"E McKenzie","year":"2023","unstructured":"McKenzie\u00a0E, Zhang\u00a0S, Zakariaee\u00a0R et\u00a0al (2023) Left anterior descending coronary artery radiation dose association with all-cause mortality in NRG Oncology trial RTOG 0617. Int J Radiat Oncol Biol Phys 115(5):1138\u20131143","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2561_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.110061","volume":"191","author":"X Chen","year":"2024","unstructured":"Chen\u00a0X, Mumme\u00a0RP, Corrigan\u00a0KL et\u00a0al (2024) Deep learning-based automatic segmentation of cardiac substructures for lung cancers. Radiother Oncol 191:110061","journal-title":"Radiother Oncol"},{"issue":"1","key":"2561_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s13246-023-01231-w","volume":"46","author":"RN Finnegan","year":"2023","unstructured":"Finnegan\u00a0RN, Chin\u00a0V, Chlap\u00a0P et\u00a0al (2023) Open-source, fully-automated hybrid cardiac substructure segmentation: development and optimisation. Phys Eng Sci Med 46(1):377\u2013393","journal-title":"Phys Eng Sci Med"},{"issue":"3","key":"2561_CR11","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.ijrobp.2024.05.013","volume":"120","author":"N Summerfield","year":"2024","unstructured":"Summerfield\u00a0N, Morris\u00a0E, Banerjee\u00a0S et\u00a0al (2024) Enhancing precision in cardiac segmentation for magnetic resonance-guided radiation therapy through deep learning. Int J Radiat Oncol Biol Phys 120(3):904\u2013914","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2561_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.radonc.2012.10.016","volume":"106","author":"HD Nissen","year":"2013","unstructured":"Nissen\u00a0HD, Appelt\u00a0AL (2013) Improved heart, lung and target dose with deep inspiration breath hold in a\u00a0large clinical series of breast cancer patients. Radiother Oncol 106(1):28\u201332","journal-title":"Radiother Oncol"},{"issue":"1","key":"2561_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/jmrs.89","volume":"62","author":"LM Smyth","year":"2015","unstructured":"Smyth\u00a0LM, Knight\u00a0KA, Aarons\u00a0YK, Wasiak\u00a0J (2015) The cardiac dose-sparing benefits of deep inspiration breath-hold in left breast irradiation: a systematic review. J\u00a0Med Radiat Sci 62(1):66\u201373","journal-title":"J Med Radiat Sci"},{"issue":"2","key":"2561_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ijrobp.2021.05.110","volume":"111","author":"RW Mutter","year":"2021","unstructured":"Mutter\u00a0RW, Choi\u00a0JI, Jimenez\u00a0RB et\u00a0al (2021) Proton therapy for breast cancer: a\u00a0consensus statement from the Particle Therapy Cooperative Group breast cancer subcommittee. Int J Radiat Oncol Biol Phys 111(2):337\u2013350","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2561_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.radonc.2017.11.032","volume":"126","author":"L Henke","year":"2018","unstructured":"Henke\u00a0L, Kashani\u00a0R, Robinson\u00a0C et\u00a0al (2018) Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen. Radiother Oncol 126(3):519\u2013526","journal-title":"Radiother Oncol"},{"issue":"41","key":"2561_CR16","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon\u00a0AR, L\u00f3pez-Fern\u00e1ndez\u00a0T, Couch\u00a0LS et\u00a0al (2022) 2022 ESC Guidelines on cardio-oncology developed in collaboration with EHA, ESTRO and IC-OS. Eur Heart J 43(41):4229\u20134361","journal-title":"Eur Heart J"},{"issue":"12","key":"2561_CR17","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.jtho.2024.09.1433","volume":"19","author":"A Amini","year":"2024","unstructured":"Amini\u00a0A, Zaha\u00a0VG, Hamad\u00a0E et\u00a0al (2024) American Radium Society Appropriate Use Criteria on Cardiac Toxicity Prevention and Management After Thoracic Radiotherapy. J\u00a0Thorac Oncol 19(12):1654\u20131667","journal-title":"J Thorac Oncol"},{"issue":"3 Suppl","key":"2561_CR18","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.ijrobp.2009.04.093","volume":"76","author":"G Gagliardi","year":"2010","unstructured":"Gagliardi\u00a0G, Constine\u00a0LS, Moiseenko\u00a0V et\u00a0al (2010) Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 76(3 Suppl):S77\u2013S85","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2561_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"JD Bradley","year":"2015","unstructured":"Bradley\u00a0JD, Paulus\u00a0R, Komaki\u00a0R et\u00a0al (2015) Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617). Lancet Oncol 16(2):187\u2013199","journal-title":"Lancet Oncol"},{"issue":"11","key":"2561_CR20","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1200\/JCO.2016.69.8480","volume":"35","author":"VA van den Bogaard","year":"2017","unstructured":"van den Bogaard\u00a0VA, Ta\u00a0BD, van der Schaaf\u00a0A et\u00a0al (2017) Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures. J\u00a0Clin Oncol 35(11):1171\u20131178","journal-title":"J Clin Oncol"},{"key":"2561_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2022.109453","volume":"180","author":"M Holm","year":"2023","unstructured":"Holm\u00a0M, Slot\u00a0M, Bisballe\u00a0N et\u00a0al (2023) Radiation dose to heart and cardiac substructures and risk of coronary artery disease in early breast cancer patients: a\u00a0DBCG study based on modern radiation therapy techniques. Radiother Oncol 180:109453","journal-title":"Radiother Oncol"},{"issue":"4","key":"2561_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1200\/JCO.2011.34.5900","volume":"30","author":"G Nilsson","year":"2012","unstructured":"Nilsson\u00a0G, Holmberg\u00a0L, Garmo\u00a0H et\u00a0al (2012) Distribution of coronary artery stenosis after radiation for breast cancer. J\u00a0Clin Oncol 30(4):380\u2013386","journal-title":"J Clin Oncol"},{"issue":"1","key":"2561_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-019-1242-z","volume":"14","author":"AK Wennstig","year":"2019","unstructured":"Wennstig\u00a0AK, Garmo\u00a0H, Isacsson\u00a0U et\u00a0al (2019) The relationship between radiation doses to coronary arteries and location of coronary stenosis requiring intervention in breast cancer survivors. Radiat Oncol 14(1):40","journal-title":"Radiat Oncol"},{"issue":"1","key":"2561_CR24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.radonc.2011.07.012","volume":"100","author":"K Erven","year":"2011","unstructured":"Erven\u00a0K, Jurcut\u00a0R, Giang\u00a0KS et\u00a0al (2011) Changes in cardiac function during and after adjuvant radiotherapy for breast cancer with and without chemotherapy. Radiother Oncol 100(1):116\u2013121","journal-title":"Radiother Oncol"},{"issue":"25 Pt A","key":"2561_CR25","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","volume":"63","author":"P Thavendiranathan","year":"2014","unstructured":"Thavendiranathan\u00a0P, Poulin\u00a0F, Lim\u00a0KD et\u00a0al (2014) Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a\u00a0systematic review. J\u00a0Am Coll Cardiol 63(25 Pt A):2751\u20132768","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2561_CR26","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.ahj.2004.12.026","volume":"150","author":"PA Heidenreich","year":"2005","unstructured":"Heidenreich\u00a0PA, Hancock\u00a0SL, Vagelos\u00a0RH, Lee\u00a0BK, Schnittger\u00a0I (2005) Diastolic dysfunction after mediastinal irradiation. Am Heart J 150(5):977\u2013982","journal-title":"Am Heart J"},{"issue":"1","key":"2561_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.radonc.2010.09.002","volume":"97","author":"J Yarnold","year":"2010","unstructured":"Yarnold\u00a0J, Brotons\u00a0MC (2010) Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol 97(1):149\u2013161","journal-title":"Radiother Oncol"},{"issue":"5","key":"2561_CR28","doi-asserted-by":"publisher","first-page":"e639","DOI":"10.1016\/j.ijrobp.2012.07.2362","volume":"84","author":"G Ghobadi","year":"2012","unstructured":"Ghobadi\u00a0G, van der Veen\u00a0S, Bartelds\u00a0B et\u00a0al (2012) Physiological interaction of heart and lung in thoracic irradiation. Int J Radiat Oncol Biol Phys 84(5):e639\u2013e646","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"2561_CR29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/heartjnl-2019-315852","volume":"106","author":"M Imazio","year":"2020","unstructured":"Imazio\u00a0M, Colopi\u00a0M, De Ferrari\u00a0GM (2020) Pericardial diseases in patients with cancer: contemporary prevalence, management and outcomes. Heart 106(8):569\u2013574","journal-title":"Heart"},{"issue":"8","key":"2561_CR30","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0046-8177(96)90447-5","volume":"27","author":"JP Veinot","year":"1996","unstructured":"Veinot\u00a0JP, Edwards\u00a0WD (1996) Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol 27(8):766\u2013773","journal-title":"Hum Pathol"},{"issue":"4","key":"2561_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv008","volume":"107","author":"DJ Cutter","year":"2015","unstructured":"Cutter\u00a0DJ, Schaapveld\u00a0M, Darby\u00a0SC et\u00a0al (2015) Risk of valvular heart disease after treatment for Hodgkin lymphoma. J\u00a0Natl Cancer Inst 107(4):djv008","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2561_CR32","first-page":"681","volume":"10","author":"MD Brand","year":"2001","unstructured":"Brand\u00a0MD, Abadi\u00a0CA, Engel\u00a0JA, Jorge\u00a0JM (2001) Radiation-associated valvular heart disease in Hodgkin\u2019s disease is associated with characteristic thickening and fibrosis of the aortic-mitral curtain. J\u00a0Heart Valve Dis 10(5):681\u2013685","journal-title":"J Heart Valve Dis"},{"issue":"4","key":"2561_CR33","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0735-1097(03)00759-9","volume":"42","author":"PA Heidenreich","year":"2003","unstructured":"Heidenreich\u00a0PA, Hancock\u00a0SL, Lee\u00a0BK, Mariscal\u00a0CS, Schnittger\u00a0I (2003) Asymptomatic cardiac disease following mediastinal irradiation. J\u00a0Am Coll Cardiol 42(4):743\u2013749","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2561_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.clon.2023.11.029","volume":"36","author":"GM Walls","year":"2024","unstructured":"Walls\u00a0GM, O\u2019Connor\u00a0J, Harbinson\u00a0M et\u00a0al (2024) The association of incidental radiation dose to the heart base with overall survival and cardiac events after curative-intent radiotherapy for NSCLC: results from the NI-HEART study. Clin Oncol 36(2):119\u2013127","journal-title":"Clin Oncol"},{"issue":"1","key":"2561_CR35","volume":"6","author":"T Marchant","year":"2024","unstructured":"Marchant\u00a0T, Price\u00a0G, McWilliam\u00a0A et\u00a0al (2024) Assessment of heart-substructures auto-contouring accuracy for application in heart-sparing radiotherapy for lung cancer. BJR Open 6(1):tzae006","journal-title":"BJR Open"},{"issue":"8","key":"2561_CR36","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/1754-9485.13668","volume":"68","author":"RN Finnegan","year":"2024","unstructured":"Finnegan\u00a0RN, Quinn\u00a0A, Belous\u00a0G et\u00a0al (2024) Cardiac substructure delineation in radiation therapy \u2013 a state-of-the-art review. J\u00a0Med Imaging Radiat Oncol 68(8):914\u2013949","journal-title":"J Med Imaging Radiat Oncol"},{"key":"2561_CR37","volume":"29","author":"G Fernandes M","year":"2024","unstructured":"Fernandes M\u00a0G, Bussink\u00a0J, Stam\u00a0B et\u00a0al (2024) Deep learning model for automatic contouring of cardiovascular substructures on radiotherapy planning CT images: dosimetric validation and reader study based clinical acceptability testing. Phys Imaging Radiat Oncol 29:100533","journal-title":"Phys Imaging Radiat Oncol"},{"issue":"4","key":"2561_CR38","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/mp.16846","volume":"51","author":"X Jin","year":"2024","unstructured":"Jin\u00a0X, Hao\u00a0Y, Hilliard\u00a0J et\u00a0al (2024) A quality assurance framework for routine monitoring of deep learning cardiac substructure CT segmentation models in radiotherapy. Med Phys 51(4):2741\u20132758","journal-title":"Med Phys"},{"issue":"12","key":"2561_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103993","volume":"9","author":"S Sch\u00f6necker","year":"2024","unstructured":"Sch\u00f6necker\u00a0S, Angelini\u00a0L, Gaasch\u00a0A et\u00a0al (2024) Surface-based deep inspiration breath-hold radiotherapy in left-sided breast cancer: final results from the SAVE-HEART study. ESMO Open 9(12):103993","journal-title":"ESMO Open"},{"key":"2561_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109734","volume":"185","author":"MC Aznar","year":"2023","unstructured":"Aznar\u00a0MC, de Fez Carrasco\u00a0P, Corradini\u00a0S et\u00a0al (2023) ESTRO-ACROP guideline: recommendations on implementation of breath-hold techniques in radiotherapy. Radiother Oncol 185:109734","journal-title":"Radiother Oncol"},{"key":"2561_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0345614","author":"PY Chiang","year":"2026","unstructured":"Chiang\u00a0PY, Huang\u00a0PJ, Hung\u00a0CH et\u00a0al (2026) Deep inspiration breath hold versus free breathing in postoperative radiotherapy for left-sided breast cancer treated with VMAT: a\u00a0meta-analysis and systematic review. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0345614","journal-title":"PLOS ONE"},{"issue":"4","key":"2561_CR42","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jaccao.2024.04.009","volume":"6","author":"C Busschaert","year":"2024","unstructured":"Busschaert\u00a0C et\u00a0al (2024) Deep inspiration breath hold in left-sided breast radiotherapy: a\u00a0balance between side effects and costs. JACC CardioOncol 6(4):514\u2013525","journal-title":"JACC CardioOncol"},{"key":"2561_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7762(25)00301-1","author":"C Busschaert","year":"2025","unstructured":"Busschaert\u00a0C et\u00a0al (2025) Deep inspiration breath-hold for breast cancer radiotherapy: a modelling study of targeted versus non-targeted strategy. Lancet Reg Health Eur. https:\/\/doi.org\/10.1016\/S2666-7762(25)00301-1","journal-title":"Lancet Reg Health Eur"},{"key":"2561_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104538","volume":"204","author":"IC Costin","year":"2024","unstructured":"Costin\u00a0IC, Marcu\u00a0LG (2024) Cardio-oncology concerns in radiotherapy: heart and cardiac substructure toxicities from modern delivery techniques. Crit Rev Oncol Hematol 204:104538","journal-title":"Crit Rev Oncol Hematol"},{"issue":"18","key":"2561_CR45","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1200\/JCO.2017.74.0720","volume":"36","author":"Z Liao","year":"2018","unstructured":"Liao\u00a0Z, Lee\u00a0JJ, Komaki\u00a0R et\u00a0al (2018) Bayesian adaptive randomization trial of passive scattering proton therapy and intensity-modulated photon radiotherapy for locally advanced non-small-cell lung cancer. J\u00a0Clin Oncol 36(18):1813\u20131822","journal-title":"J Clin Oncol"},{"issue":"5","key":"2561_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2023.101235","volume":"8","author":"J Natarajan","year":"2023","unstructured":"Natarajan\u00a0J, Yegya-Raman\u00a0N, Kegelman\u00a0TP et\u00a0al (2023) Cardiovascular substructure dose and cardiac events following proton- and photon-based chemoradiotherapy for non-small cell lung cancer. Adv Radiat Oncol 8(5):101235","journal-title":"Adv Radiat Oncol"},{"issue":"3","key":"2561_CR47","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.3390\/curroncol30030219","volume":"30","author":"L O\u2019Steen","year":"2023","unstructured":"O\u2019Steen\u00a0L, Trager\u00a0M, Gupta\u00a0A, Jimenez\u00a0RB (2023) The potential of proton therapy for locally advanced breast cancer: clinical and technical considerations. Curr Oncol 30(3):2869\u20132878","journal-title":"Curr Oncol"},{"key":"2561_CR48","doi-asserted-by":"crossref","unstructured":"MacDonald SM, Cahlon O, Bekelman JE, et\u00a0al. Phase\u00a0III randomized trial of proton vs. photon therapy for patients with non-metastatic breast cancer receiving comprehensive nodal radiation: RadComp Consortium Trial \u2014 health-related quality of life outcomes. Late-breaking abstract, ASTRO 2025. Int J Radiat Oncol Biol Phys. 2025.","DOI":"10.1016\/j.ijrobp.2025.08.025"},{"issue":"6","key":"2561_CR49","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/j.prro.2024.06.007","volume":"14","author":"DS Bruno","year":"2024","unstructured":"Bruno\u00a0DS et\u00a0al (2024) A pilot trial of proton-based cardiac sparing accelerated fractionated radiation therapy in unresectable non-small cell lung cancer with extended durvalumab therapy (PARTICLE-D). Pract Radiat Oncol 14(6):e438\u2013e442","journal-title":"Pract Radiat Oncol"},{"key":"2561_CR50","doi-asserted-by":"publisher","DOI":"10.1177\/15330338241234788","volume":"23","author":"XY Wu","year":"2024","unstructured":"Wu\u00a0XY, Chen\u00a0M, Cao\u00a0L, Li\u00a0M, Chen\u00a0JY (2024) Proton therapy in breast cancer: a review of potential approaches for patient selection. Technol Cancer Res Treat 23:15330338241234788","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"2561_CR51","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1002\/mp.17024","volume":"51","author":"O Akdag","year":"2024","unstructured":"Akdag\u00a0O, Borman\u00a0PTS, Mandija\u00a0S et\u00a0al (2024) Experimental demonstration of real-time cardiac physiology-based radiotherapy gating for improved cardiac radioablation on an MR-linac. Med Phys 51(4):2354\u20132366","journal-title":"Med Phys"},{"key":"2561_CR52","volume":"45","author":"LG Merckel","year":"2024","unstructured":"Merckel\u00a0LG, Pomp\u00a0J, Hackett\u00a0SL et\u00a0al (2024) Stereotactic body radiotherapy of central lung tumours using a 1.5 T MR-linac: first clinical experiences. Clin Transl Radiat Oncol 45:100744","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"2561_CR53","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/mp.16028","volume":"50","author":"LHG van der Pol","year":"2023","unstructured":"van der Pol\u00a0LHG, Hackett\u00a0SL, Hoesein\u00a0FAAM et\u00a0al (2023) On the feasibility of cardiac substructure sparing in magnetic resonance imaging guided stereotactic lung radiotherapy. Med Phys 50(1):397\u2013409","journal-title":"Med Phys"},{"key":"2561_CR54","doi-asserted-by":"crossref","unstructured":"Gregg KW, Ruff C, Koenig G, et\u00a0al. Development and first implementation of a\u00a0novel multi-modality cardiac motion and dosimetry phantom for radiotherapy applications. Med Phys. 2024;51(10):7479\u20137491.","DOI":"10.1002\/mp.17315"},{"key":"2561_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109970","volume":"190","author":"E Lombardo","year":"2024","unstructured":"Lombardo\u00a0E, Dhont\u00a0J, Page\u00a0D et\u00a0al (2024) Real-time motion management in MRI-guided radiotherapy: current status and AI-enabled prospects. Radiother Oncol 190:109970","journal-title":"Radiother Oncol"},{"issue":"245","key":"2561_CR56","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008973","volume":"6","author":"V Favaudon","year":"2014","unstructured":"Favaudon\u00a0V, Caplier\u00a0L, Monceau\u00a0V et\u00a0al (2014) Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in a mouse model. Sci Transl Med 6(245):245ra 93","journal-title":"Sci Transl Med"},{"issue":"4","key":"2561_CR57","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.ijrobp.2024.01.224","volume":"119","author":"K Kim","year":"2024","unstructured":"Kim\u00a0K, Kim\u00a0MM, Skoufos\u00a0G et\u00a0al (2024) FLASH proton radiation therapy mitigates inflammatory and fibrotic pathways and preserves cardiac function in a preclinical mouse model of radiation-induced heart disease. Int J Radiat Oncol Biol Phys 119(4):1234\u20131247","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2561_CR58","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jamaoncol.2022.5843","volume":"9","author":"AE Mascia","year":"2023","unstructured":"Mascia\u00a0AE, Daugherty\u00a0EC, Zhang\u00a0Y et\u00a0al (2023) Proton FLASH radiotherapy for the treatment of symptomatic bone metastases: the FAST-01 nonrandomized trial. JAMA Oncol 9(1):62\u201369","journal-title":"JAMA Oncol"},{"issue":"1","key":"2561_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-024-02419-4","volume":"19","author":"EC Daugherty","year":"2024","unstructured":"Daugherty\u00a0EC, Zhang\u00a0Y, Xiao\u00a0Z et\u00a0al (2024) FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach. Radiat Oncol 19(1):34","journal-title":"Radiat Oncol"},{"key":"2561_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110507","volume":"200","author":"TT B\u00f6hlen","year":"2024","unstructured":"B\u00f6hlen\u00a0TT, Psoroulas\u00a0S, Aylward\u00a0JD et\u00a0al (2024) Recording and reporting of ultra-high dose rate \u201cFLASH\u201d delivery for preclinical and clinical settings. Radiother Oncol 200:110507","journal-title":"Radiother Oncol"},{"key":"2561_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-015-0436-2","volume":"10","author":"T Skytt\u00e4","year":"2015","unstructured":"Skytt\u00e4\u00a0T, Tuohinen\u00a0S, Boman\u00a0E et\u00a0al (2015) Troponin T\u2011release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy. Radiat Oncol 10:141","journal-title":"Radiat Oncol"},{"issue":"2","key":"2561_CR62","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1016\/j.ijrobp.2011.03.058","volume":"82","author":"MP D\u2019Errico","year":"2012","unstructured":"D\u2019Errico\u00a0MP, Grimaldi\u00a0L, Petruzzelli\u00a0MF et\u00a0al (2012) N\u2011terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer. Int J Radiat Oncol Biol Phys 82(2):e239\u2013e246","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2561_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110479","volume":"200","author":"JC Beukema","year":"2024","unstructured":"Beukema\u00a0JC, Haveman\u00a0JW, Langendijk\u00a0JA et\u00a0al (2024) Blood biomarkers for cardiac damage during and after radiotherapy for esophageal cancer: a prospective cohort study. Radiother Oncol 200:110479","journal-title":"Radiother Oncol"},{"issue":"10","key":"2561_CR64","doi-asserted-by":"publisher","first-page":"9049","DOI":"10.3390\/curroncol30100654","volume":"30","author":"K Antunac","year":"2023","unstructured":"Antunac\u00a0K, Mayer\u00a0L, Banovic\u00a0M, Beketic-Oreskovic\u00a0L (2023) Correlation of high-sensitivity cardiac troponin I values and cardiac radiation doses in patients with left-sided breast cancer undergoing hypofractionated adjuvant radiotherapy with concurrent anti-HER2 therapy. Curr Oncol 30(10):9049\u20139062","journal-title":"Curr Oncol"},{"issue":"3","key":"2561_CR65","doi-asserted-by":"publisher","first-page":"365","DOI":"10.21873\/cdp.10225","volume":"3","author":"V Cirnigliaro","year":"2023","unstructured":"Cirnigliaro\u00a0V, Pietrosanti\u00a0S, Demofonti\u00a0C et\u00a0al (2023) V5 and high sensitivity cardiac troponin T for early detection of cardiac toxicity during left breast cancer irradiation. Cancer Diagn Progn 3(3):365\u2013369","journal-title":"Cancer Diagn Progn"},{"issue":"11","key":"2561_CR66","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s11886-023-01971-x","volume":"25","author":"W Schiffer","year":"2023","unstructured":"Schiffer\u00a0W, Pedersen\u00a0LN, Lui\u00a0M, Bergom\u00a0C, Mitchell\u00a0JD (2023) Advances in screening for radiation-associated cardiotoxicity in cancer patients. Curr Cardiol Rep 25(11):1589\u20131600","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"2561_CR67","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/cvr\/cvac087","volume":"119","author":"C Tonry","year":"2023","unstructured":"Tonry\u00a0C, Russell-Hallinan\u00a0A, McCune\u00a0C et\u00a0al (2023) Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction. Cardiovasc Res 119(3):710\u2013728","journal-title":"Cardiovasc Res"},{"key":"2561_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.15363","author":"Y Wang","year":"2025","unstructured":"Wang\u00a0Y, Wu\u00a0T, Gao\u00a0X et\u00a0al (2025) Early diagnostic value of novel biomarkers for breast cancer therapy-related cardiac dysfunction. ESC Heart Fail. https:\/\/doi.org\/10.1002\/ehf2.15363","journal-title":"ESC Heart Fail"},{"issue":"1","key":"2561_CR69","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jaccao.2023.10.008","volume":"6","author":"A Mecinaj","year":"2024","unstructured":"Mecinaj\u00a0A, Gulati\u00a0G, Ree\u00a0AH et\u00a0al (2024) Impact of the ESC cardio-oncology guidelines biomarker criteria on incidence of cancer therapy\u2013related cardiac dysfunction. JACC CardioOncol 6(1):83\u201395","journal-title":"JACC CardioOncol"},{"key":"2561_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-025-02668-x","author":"Y Luo","year":"2025","unstructured":"Luo\u00a0Y et\u00a0al (2025) Radiation-induced cardiac substructure damage and dose constraints: a review. Radiat Oncol. https:\/\/doi.org\/10.1186\/s13014-025-02668-x","journal-title":"Radiat Oncol"},{"key":"2561_CR71","doi-asserted-by":"crossref","unstructured":"Research progress in the prevention and treatment of radiation-induced heart disease. Front Pharmacol. 2025;16:1745302.","DOI":"10.3389\/fphar.2025.1745302"},{"issue":"10","key":"2561_CR72","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.clon.2013.06.012","volume":"25","author":"FA Stewart","year":"2013","unstructured":"Stewart\u00a0FA, Seemann\u00a0I, Hoving\u00a0S, Russell\u00a0NS (2013) Understanding radiation-induced cardiovascular damage and strategies for intervention. Clin Oncol (R\u00a0Coll Radiol) 25(10):617\u2013624","journal-title":"Clin Oncol (R\u00a0Coll Radiol)"},{"issue":"20","key":"2561_CR73","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036411","volume":"13","author":"YJ Huang","year":"2024","unstructured":"Huang\u00a0YJ, Lin\u00a0JA, Chen\u00a0WM, Shia\u00a0BC, Wu\u00a0SY (2024) Statin therapy reduces radiation-induced cardiotoxicity in patients with breast cancer receiving adjuvant radiotherapy. J\u00a0Am Heart Assoc 13(20):e036411","journal-title":"J Am Heart Assoc"},{"key":"2561_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.110004","volume":"190","author":"GM Walls","year":"2024","unstructured":"Walls\u00a0GM, Ghita\u00a0M, Herron\u00a0B et\u00a0al (2024) A\u00a0multimodality assessment of the protective capacity of statin therapy in a\u00a0mouse model of radiation cardiotoxicity. Radiother Oncol 190:110004","journal-title":"Radiother Oncol"},{"key":"2561_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109762","volume":"186","author":"GM Walls","year":"2023","unstructured":"Walls\u00a0GM, O\u2019Connor\u00a0J, Harbinson\u00a0M et\u00a0al (2023) Association between statin therapy dose intensity and radiation cardiotoxicity in non-small cell lung cancer: results from the NI-HEART study. Radiother Oncol 186:109762","journal-title":"Radiother Oncol"},{"key":"2561_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s40959-025-00439-x","volume":"12","author":"V Pakeerathan","year":"2026","unstructured":"Pakeerathan\u00a0V, Marwah\u00a0R, Mohammed\u00a0AR, Smith\u00a0J (2026) Cardioprotective medications and the incidence of cardiovascular events in patients treated with radiotherapy: a systematic review and meta-analysis. Cardio-Oncology 12:22","journal-title":"Cardio-Oncology"},{"issue":"21","key":"2561_CR77","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1093\/eurheartj\/ehw022","volume":"37","author":"G Gulati","year":"2016","unstructured":"Gulati\u00a0G, Heck\u00a0SL, Ree\u00a0AH et\u00a0al (2016) Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 \u00d7 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol. Eur Heart J 37(21):1671\u20131680","journal-title":"Eur Heart J"},{"key":"2561_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103788","volume":"77","author":"TY Lai","year":"2024","unstructured":"Lai\u00a0TY, Hu\u00a0YW, Wang\u00a0TH et\u00a0al (2024) Estimating the risk of major adverse cardiac events following radiotherapy for left breast cancer using a\u00a0modified generalized Lyman NTCP model. Breast 77:103788","journal-title":"Breast"},{"issue":"4","key":"2561_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.14614","volume":"26","author":"A Talebi","year":"2025","unstructured":"Talebi\u00a0A, Bitarafan-Rajabi\u00a0A, Alizadeh-Asl\u00a0A et\u00a0al (2025) Machine learning based radiomics model to predict radiotherapy induced cardiotoxicity in breast cancer. J\u00a0Appl Clin Med Phys 26(4):e14614","journal-title":"J Appl Clin Med Phys"},{"issue":"6","key":"2561_CR80","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jaccao.2023.08.007","volume":"5","author":"HJ No","year":"2023","unstructured":"No\u00a0HJ, Guo\u00a0FB, Park\u00a0NJI et\u00a0al (2023) Predicting adverse cardiac events after radiotherapy for locally advanced non\u2013small cell lung cancer. JACC CardioOncol 5(6):775\u2013787","journal-title":"JACC CardioOncol"},{"key":"2561_CR81","volume":"39","author":"P Samant","year":"2023","unstructured":"Samant\u00a0P, de Ruysscher\u00a0D, Hoebers\u00a0F et\u00a0al (2023) Machine learning for normal tissue complication probability prediction: predictive power with versatility and easy implementation. Clin Transl Radiat Oncol 39:100595","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"2561_CR82","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jaccao.2022.10.010","volume":"5","author":"JA Sparano","year":"2023","unstructured":"Sparano\u00a0JA, Sahni\u00a0G (2023) The ESC cardio-oncology guidelines: a\u00a0roadmap for clinical practice. JACC CardioOncol 5(1):96\u201399","journal-title":"JACC CardioOncol"},{"issue":"5","key":"2561_CR83","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jaccao.2024.07.017","volume":"6","author":"Z Raisi-Estabragh","year":"2024","unstructured":"Raisi-Estabragh\u00a0Z, Murphy\u00a0AC, Ramalingam\u00a0S et\u00a0al (2024) Cardiovascular considerations before cancer therapy: gaps in evidence and JACC: CardioOncology expert panel recommendations. JACC CardioOncol 6(5):631\u2013654","journal-title":"JACC CardioOncol"},{"issue":"6","key":"2561_CR84","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jaccao.2024.06.005","volume":"6","author":"DP Leong","year":"2024","unstructured":"Leong\u00a0DP, Waliany\u00a0S, Abdel-Qadir\u00a0H et\u00a0al (2024) Cardiovascular considerations during cancer therapy: gaps in evidence and JACC: CardioOncology expert panel recommendations. JACC CardioOncol 6(6):815\u2013834","journal-title":"JACC CardioOncol"},{"key":"2561_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2024.06.006","author":"O Calvillo-Arguelles","year":"2025","unstructured":"Calvillo-Arguelles\u00a0O et\u00a0al (2025) Cardiovascular considerations after cancer therapy: gaps in evidence and JACC: CardioOncology expert panel recommendations. JACC CardioOncol. https:\/\/doi.org\/10.1016\/j.jaccao.2024.06.006","journal-title":"JACC CardioOncol"},{"issue":"12","key":"2561_CR86","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.clon.2024.09.001","volume":"36","author":"GM Walls","year":"2024","unstructured":"Walls\u00a0GM, Mitchell\u00a0JD, Lyon\u00a0AR, Harbinson\u00a0M, Hanna\u00a0GG (2024) Radiation oncology opinions and practice on cardiotoxicity in lung cancer: a\u00a0cross-sectional study by the International Cardio-Oncology Society. Clin Oncol 36(12):745\u2013756","journal-title":"Clin Oncol"},{"issue":"10","key":"2561_CR87","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/jamaoncol.2024.3065","volume":"10","author":"DL Nielsen","year":"2024","unstructured":"Nielsen\u00a0DL, Juhl\u00a0CB, Nielsen\u00a0OH, Chen\u00a0IM, Herrmann\u00a0J (2024) Immune checkpoint inhibitor\u2013induced cardiotoxicity: a\u00a0systematic review and meta-analysis. JAMA Oncol 10(10):1390\u20131399","journal-title":"JAMA Oncol"},{"key":"2561_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.110005","volume":"190","author":"N Yegya-Raman","year":"2024","unstructured":"Yegya-Raman\u00a0N, Lee\u00a0SH, Friedes\u00a0C et\u00a0al (2024) Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced NSCLC in the era of immune checkpoint inhibitor consolidation. Radiother Oncol 190:110005","journal-title":"Radiother Oncol"},{"issue":"10","key":"2561_CR89","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/ejhf.3340","volume":"26","author":"CG Tocchetti","year":"2024","unstructured":"Tocchetti\u00a0CG, Farmakis\u00a0D, Koop\u00a0Y et\u00a0al (2024) Cardiovascular toxicities of immune therapies for cancer \u2013 a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology. Eur J Heart Fail 26(10):2055\u20132076","journal-title":"Eur J Heart Fail"},{"key":"2561_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110591","volume":"202","author":"F De Rose","year":"2025","unstructured":"De Rose\u00a0F, De Santis\u00a0MC, Lucidi\u00a0S et\u00a0al (2025) Dose constraints in breast cancer radiotherapy: a critical review. Radiother Oncol 202:110591","journal-title":"Radiother Oncol"},{"key":"2561_CR91","volume":"45","author":"L Vaugier","year":"2024","unstructured":"Vaugier\u00a0L, Martin-Mervoyer\u00a0E, Ah-Thiane\u00a0L et\u00a0al (2024) How to contour the different heart subregions for future deep-learning modeling of the heart: a\u00a0practical pictorial proposal for radiation oncologists. Clin Transl Radiat Oncol 45:100718","journal-title":"Clin Transl Radiat Oncol"},{"issue":"6","key":"2561_CR92","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.clon.2023.03.005","volume":"35","author":"V Chin","year":"2023","unstructured":"Chin\u00a0V, Finnegan\u00a0RN, Chlap\u00a0P et\u00a0al (2023) Validation of a\u00a0fully automated hybrid deep learning cardiac substructure segmentation tool for contouring and dose evaluation in lung cancer radiotherapy. Clin Oncol 35(6):370\u2013381","journal-title":"Clin Oncol"},{"key":"2561_CR93","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejca.2017.07.053","volume":"85","author":"A McWilliam","year":"2017","unstructured":"McWilliam\u00a0A, Kennedy\u00a0J, Hodgson\u00a0C et\u00a0al (2017) Radiation dose to heart base linked with poorer survival in lung cancer patients. Eur J Cancer 85:106\u2013113","journal-title":"Eur J Cancer"},{"key":"2561_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-00761-6","author":"SC Zhang","year":"2025","unstructured":"Zhang\u00a0SC et\u00a0al (2025) Early cardio-oncology intervention in thoracic radiotherapy: prospective single-arm pilot study. Commun Med. https:\/\/doi.org\/10.1038\/s43856-025-00761-6","journal-title":"Commun Med"},{"key":"2561_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00651-5","author":"Y Kim","year":"2025","unstructured":"Kim\u00a0Y, Bates\u00a0JE, Yoon\u00a0HI, Grassberger\u00a0C (2025) Cardiac radiosensitivity in the era of thoracic chemoradiotherapy and immunotherapy: a scoping review. Lancet Oncol. https:\/\/doi.org\/10.1016\/S1470-2045(25)00651-5","journal-title":"Lancet Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02561-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-026-02561-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02561-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:02:45Z","timestamp":1793865765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-026-02561-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":95,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2561"],"URL":"https:\/\/doi.org\/10.1007\/s00066-026-02561-w","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.\u00a0Sohaib, M.T.\u00a0Amin, and M.\u00a0Alhefny declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this is a\u00a0review article that includes no original patient data, no specific ethical approval or informed consent was required.","order":2,"name":"Ethics","label":"Ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}}]}}